These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1678151)

  • 41. Effect of L-dopa loading on 5-HTP decarboxylation in rat brain areas.
    Trouvin JH; Maubrey MC; Raynal H; Jacquot C
    Fundam Clin Pharmacol; 1991; 5(6):497-502. PubMed ID: 1720112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity.
    Invernizzi R; Carli M; Di Clemente A; Samanin R
    J Neurochem; 1991 Jan; 56(1):243-7. PubMed ID: 1824782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
    Thiblin I; Finn A; Ross SB; Stenfors C
    Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat.
    Colado MI; Ormazabal MJ; Alfaro MJ; Martin MI
    J Pharm Pharmacol; 1993 Mar; 45(3):220-2. PubMed ID: 7683338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat.
    Ahlenius S; Larsson K; Wijkström A
    Eur J Pharmacol; 1991 Aug; 200(2-3):259-66. PubMed ID: 1838333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M; Kittner B; Laschinski G
    Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
    Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W; Speckenbach W; Zimmermann R
    J Neural Transm; 1977; 40(2):129-47. PubMed ID: 323421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
    Nakamura S; Yue JL; Goshima Y; Miyamae T; Ueda H; Misu Y
    Neurosci Lett; 1994 Mar; 170(1):22-6. PubMed ID: 7913743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
    Koller WC; Herbster G
    Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Interactions of cerebral serotonin and catecholamines].
    Watanabe Y
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Audiogenic seizures: relation to age and mechanisms of monoamine neurotransmission.
    Kellogg C
    Brain Res; 1976 Apr; 106(1):87-103. PubMed ID: 1083762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of restraint stress and anxiolytics on 5-HT turnover in rat brain.
    Mitchell SN; Thomas PJ
    Pharmacology; 1988; 37(2):105-13. PubMed ID: 2905483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.